Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol

Alemtuzumab, a humanized monoclonal antibody that targets surface molecule CD52, causes rapid and complete depletion of circulating T- and B-lymphocytes through antibody-dependent cell-mediated and complement-mediated cytotoxicity. Alemtuzumab has demonstrated superior efficacy compared to subcutane...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarvepalli, Deepika, Rashid, Mamoon Ur, Ullah, Waqas, Zafar, Yousaf, Khan, Muzammil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823085/
https://www.ncbi.nlm.nih.gov/pubmed/31720183
http://dx.doi.org/10.7759/cureus.5715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823085/
https://www.ncbi.nlm.nih.gov/pubmed/31720183
http://dx.doi.org/10.7759/cureus.5715

Ejemplares similares